Published in
Springer, Investigational New Drugs, 3(36), p. 416-423, 2017
DOI: 10.1007/s10637-017-0513-5
Links
Tools
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer
Journal article published in 2017 by
Shumei Kato,
Denis L. Jardim,
Faye M. Johnson,
Vivek Subbiah,
Sarina Piha-Paul 
,
Apostolia M. Tsimberidou,
Gerald S. Falchook,
Daniel Karp,
Ralph Zinner,
Jennifer Wheler,
Filip Janku,
Siqing Fu ,
JoAnn Lim,
Stacie Bean,
Ly Nguyen
and other authors.
,
Apostolia M. Tsimberidou,
Gerald S. Falchook,
Daniel Karp,
Ralph Zinner,
Jennifer Wheler,
Filip Janku,
Siqing Fu ,
JoAnn Lim,
Stacie Bean,
Ly Nguyen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 